ArticleOncology letters2023

Cetuximab or nimotuzumab in combination with chemotherapy for treating recurrent/metastatic nasopharyngeal carcinoma: A meta‑analysis and systemic review.

Xiaoling Ni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.